Literature DB >> 22078068

Centromedian thalamic nuclei deep brain stimulation in refractory status epilepticus.

Antonio Valentín1, Huy Q Nguyen, Alena M Skupenova, Zaloa Agirre-Arrizubieta, Sharon Jewell, Nandini Mullatti, Nicholas F Moran, Mark P Richardson, Richard P Selway, Gonzalo Alarcón.   

Abstract

BACKGROUND: Refractory status epilepticus (RSE) is associated with high mortality. We report a potential treatment alternative. HYPOTHESIS: Deep brain stimulation (DBS) of the centromedian thalamic nuclei (CMN) can be effective in the treatment of RSE.
METHODS: Report of the evolution of RSE after DBS of the CMN in a 27-year-old man.
RESULTS: In the course of an encephalopathy of unknown origin, and after a cardiac arrest, the patient developed RSE with myoclonic jerks and generalized tonic-clonic seizures. The EEG showed continuous generalized periodic epileptiform discharges (GPEDS). Five weeks after RSE onset, bilateral DBS of the CMN was started. This treatment was immediately followed by disappearance of tonic-clonic seizures and GPEDS, suggesting a resolution of RSE. The patient continued having multifocal myoclonic jerks, probably subcortical in origin, which resolved after 4 weeks. The patient remained clinically stable for 2 months in a persistent vegetative state.
CONCLUSIONS: The remission of RSE, the abolition of GPEDS, and the patient survival suggest that DBS of the CMN may be efficacious in the treatment of refractory, generalized status epilepticus.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22078068     DOI: 10.1016/j.brs.2011.10.002

Source DB:  PubMed          Journal:  Brain Stimul        ISSN: 1876-4754            Impact factor:   8.955


  8 in total

Review 1.  Neurostimulation as a Method of Treatment and a Preventive Measure in Canine Drug-Resistant Epilepsy: Current State and Future Prospects.

Authors:  Marta Nowakowska; Muammer Üçal; Marios Charalambous; Sofie F M Bhatti; Timothy Denison; Sebastian Meller; Gregory A Worrell; Heidrun Potschka; Holger A Volk
Journal:  Front Vet Sci       Date:  2022-06-16

2.  Centromedian Nucleus of the Thalamus Deep Brain Stimulation for Genetic Generalized Epilepsy: A Case Report and Review of Literature.

Authors:  Shruti Agashe; David Burkholder; Keith Starnes; Jamie J Van Gompel; Brian N Lundstrom; Gregory A Worrell; Nicholas M Gregg
Journal:  Front Hum Neurosci       Date:  2022-05-20       Impact factor: 3.473

Review 3.  Electrical brain stimulation for epilepsy.

Authors:  Robert S Fisher; Ana Luisa Velasco
Journal:  Nat Rev Neurol       Date:  2014-04-08       Impact factor: 42.937

4.  Responsive neurostimulation for focal motor status epilepticus.

Authors:  Jimmy C Yang; Nitish M Harid; Fábio A Nascimento; Vasileios Kokkinos; Abigail Shaughnessy; Alice D Lam; M Brandon Westover; Thabele M Leslie-Mazwi; Leigh R Hochberg; Eric S Rosenthal; Andrew J Cole; Robert M Richardson; Sydney S Cash
Journal:  Ann Clin Transl Neurol       Date:  2021-05-06       Impact factor: 4.511

5.  Epilepsy and Neuromodulation-Randomized Controlled Trials.

Authors:  Churl-Su Kwon; Valeria Ripa; Omar Al-Awar; Fedor Panov; Saadi Ghatan; Nathalie Jetté
Journal:  Brain Sci       Date:  2018-04-18

Review 6.  Updates in Refractory Status Epilepticus.

Authors:  Rohit Marawar; Maysaa Basha; Advait Mahulikar; Aaron Desai; Kushak Suchdev; Aashit Shah
Journal:  Crit Care Res Pract       Date:  2018-05-08

7.  Case Report: Embedding "Digital Chronotherapy" Into Medical Devices-A Canine Validation for Controlling Status Epilepticus Through Multi-Scale Rhythmic Brain Stimulation.

Authors:  Mayela Zamora; Sebastian Meller; Filip Kajin; James J Sermon; Robert Toth; Moaad Benjaber; Derk-Jan Dijk; Rafal Bogacz; Gregory A Worrell; Antonio Valentin; Benoit Duchet; Holger A Volk; Timothy Denison
Journal:  Front Neurosci       Date:  2021-09-24       Impact factor: 4.677

8.  Deep brain stimulation for refractory epilepsy.

Authors:  Tomasz Tykocki; Tomasz Mandat; Anna Kornakiewicz; Henryk Koziara; Paweł Nauman
Journal:  Arch Med Sci       Date:  2012-10-08       Impact factor: 3.318

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.